AAP updates recommendations for infants at risk for group beta strep

  • Pediatrics

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • The American Academy of Pediatrics (AAP) has updated its recommendations for management of newborns at risk for group beta strep disease (GBS).

Why this matters

  • Recommendations accompany publication of updated guidelines from the American College of Obstetricians and Gynecologists (ACOG) for screening and management for GBS in pregnancy .
  • About 20%-30% of US pregnant people are carriers of GBS.
  • Experts note that long-term health effects of perinatal antibiotic exposure are not fully known. 

Key recommendations

  • As ACOG does, the AAP supports universal screening and antibiotic prophylaxis against maternal-infant transmission, where indicated.
  • For neonates, intrapartum penicillin (or other antibiotic, as indicated) offers sufficient prophylaxis against early-onset GBS.
  • Risk assessment for early-onset GBS in infants includes stratifying by ≥35 0/7 weeks of gestation vs those born earlier.
  • Diagnosis of early-onset GBS should involve blood or cerebrospinal fluid culture because other nonspecific lab tests are not adequate.
  • Evaluation for late-onset GBS should rely on clinical signs and GBS isolate in blood, cerebrospinal fluid, other typical sterile tissues.
  • Antibiotic therapy should be empiric but varies by age at evaluation.
  • Includes algorithm for evaluation: red flags include preterm labor, prelabor rupture of membranes (ROM), induced labor with infection concern or neonate respiratory/cardiovascular instability, indicated cesarean delivery with ROM.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit